Лоран О. Б., Велиев Е. И., Живов А. В.

Хронический простатит — одна болезнь?

ЛИТЕРАТУРА
1. Collins M. M., Stafford R. S., O’Leary M. P. et al. How common is prostatitis? A national survey of physician visits. J. Urol. (Baltimore) 1998; 159 (4): 1224—1228.
2. Nickel J. C., Teichman J. M., Gregoire M. et al. The prevalence, diagnosis, characterization and treatment of prostatitis, interstitial cystitis and epididymitis in outpatient urologic practice: The Canadian PIE study. Urology 2005; 66 (5): 935—940.
3. Krieger J. R., Nyberg L. J., Nickel J. C. NIH consensus definition and classification of prostatitis. J. A. M. A. 1999; 282 (3): 236—237.
4. Nickel J. C. Chronic prostatitis/Chronic pelvic pain syndrome. The biomedical model has failed! So, what’s next? Contemp. Urol. 2006; 6: 31—39.
5. Schaeffer A. J., Knauss J. C., Landis J. I. et al. Leukocyte an bacterial counts do not correlate with severity of symptoms in men prostatitis: The NIH chronic prostatitis cohort (CPC) study. J. Urol. (Baltimore) 2002; 168 (3): 1048—1053.
6. True L. D., Berger R. E., Rothman I. et al. Prostate histopathology in chronic prostatitis/chronic pelvic pain syndrome, a prospective biopsy study. J. Urol. (Baltimore) 1999; 162 (6): 2014—2018.
7. Nickel J. C., Roehrborn C. G., O’Leary M. P. et al. Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial. J. Urol. (Baltimore) 2007; 178 (3, pt 1): 896—900.
8. Nickel J. C., Alexander R. B., Schaeffer A. J. et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J. Urol. (Baltimore) 2003; 170 (3): 818—822.
9. Nickel J. C. The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence? Br. J. Urol. Int. 2004; 94 (9): 1230—1233.
10. Jimйnez-Cruz J. F., Tormo F. B., Gцmez J. G. Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control. J. Urol. (Baltimore) 1988; 139 (5): 967—970.
11. Мазо Е. Б., Касаткина Л. Ф., Школьников М. Е., Горчханов М. А. Синдром хронической тазовой боли или хронический простатит: взгляд с точки зрения игольчатой электромиографии мышц тазового дна. Урология 2006; 1: 43—47.
12. Kirby R. S., Lowe D., Bultitude M. I., Shuttleworth K. E. Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br. J. Urol. 1982; 54 (6): 729—731.
13. Forrest J. B., Nickel J. C., Moldwin R. M. Chronic prostatitis/Chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities. Urology; 69 (suppl. 4A): 60—63.
14. Nickel J. C., Berger R., Pontari M. Changing paradigms for chronic pain: a report from the chronic pelvic pain/chronic prostatitis scientific workshop October 19—21, 2005 Baltimore. Rev. Urol. 2006; 8 (1): 28—35.
15. Schaeffer A. J., Weidner W., Barbalias G. A. et al. Summary consensus statement: Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome. Eur. Urol. 2003; suppl. 2: 1—4.
16. Meares E. M., Stamey T. A. Bacteriological localization patterns in bacterial prostatitis and urethritis. Invest. Urol. 1968; 5 (5): 492—518.
17. Alexander R. B., Propert K. J., Schaeffer A. J. et al. Chronic prostatitis collaborative research network. Ciprofloxacin or Tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized double blind trial. Ann. Intern. Med. 2004; 141 (8): 581—589.
18. Nickel J. C., Downey J., Clark J. et al. Levofloxacin treatment for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men: a randomized placebo controlled multi-center trial. Urology 2003; 62 (4): 614—617.
19. Nickel J. C., Downey J., Johnston B. et al. Predictors of patients response to antibiotic therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J. Urol. (Baltimore) 2001; 165 (5): 1539—1544.
20. Nickel J. C., Zadeikis N., Spivey M. et al. Clinical significance of anti-microbial therapy in chronic prostatitis associated with non-traditional uropathogens. J. Urol. (Baltimore) 2005; 173 (4): S30.
21. Nickel J. C., Narayan P., MacKay J. et al. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J. Urol. (Baltimore) 2004; 171 (4): 1594—1597.
22. Cheah P. Y., Liong M. L., Yuen K. H. et al. Terazosin therapy of chronic prostatitis/chronic pelvic pain syndrome: a randomized placebo controlled trial. J. Urol. (Baltimore) 2003; 169 (2): 592—596.
23. Mehik A., Alas P., Nickel J. C. et al. Alfusozin treatment for chronic prostatititis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo controlled pilot study. Urology 2003; 62 (3): 425—429.
24. Nickel J. C., Pontari M., Moon T. et al. A randomized placebo-controlled multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of non-bacterial prostatitis. J. Urol. (Baltimore) 2003; 169 (4): 1401—1405.
25. Nickel J., Pontari J. C., Downey M. A. et al. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). Br. J. Urol. Int. 2004; 93 (7): 991—995.
26. Nickel J. C., Forrest J. B., Tomera K. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J. Urol. (Baltimore) 2005; 173 (4): 1252—1255.
27. De Rose A. F., Gallo F., Giglio M., Carmignani G. Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. Urology 2004; 63 (1): 13—16.
28. Лопаткин Н. А., Аполихин О. И., Сивков А. В. и др. Результаты мультицентрового исследования экстракта serenoa repens (Пермиксон) у больных хроническим абактериальным простатитом. Урология 2007; 5: 3—7.
29. Асламазов Э. Г., Ахвледиани Н. Д., Винаров А. З., Аляев Ю. Г. Цернилтон в лечении аденомы простаты и хронического простатита. Урология 2007; 1: 52—57.
30. Пушкарь Д. Ю., Зайцев А. В., Сегал А. С. Лонгидаза в лечении хронического простатита. Урология 2006; 6: 26—28.
31. Chuang Y. C., Chancellor M. B. The application of botulinum toxin in the prostate. J. Urol. (Baltimore) 2006; 175 (6, pt 1): 2375—2382.
32. Chuang Y. C., Yoshimura N., Wu M. et al. Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A. Eur. Urol. 2007; 51 (4): 1119—1127.
33. Wagenlehner F. M., Kees F., Weidner W. et al. Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers. Int. J. Antimicrob. Agents 2008; 31 (1): 21—26.
34. Yamamoto M., Hibi H., Satoshi K., Miyake K. Chronic bacterial prostatitis treated with intraprostatic injection of antibiotics. Scand. J. Urol. Nephrol. 1996; 30 (3): 199—202.
35. Guercini F., Pajoncini C., Bard R. et al. Echoguided drug infiltration in chronic prostatitis: results of a multi-centre study. Arch. Ital. Urol. Androl. 2005; 77 (2): 87—92.